3.81

3.81 (-2.62%)

As of Jun 14, 2022

Ikena Oncology, Inc. [IKNA]

Source: 

Company Overview

Ikena Oncology, Inc is a targeted oncology company developing precision medicines tailored to biomarker-defined patient groups with specific unmet needs. With our robust biomarker and translational approach we aim to develop targeted treatments and define patient populations who are most likely to respond to treatment.

CountryUS
Headquartersbostonmassachusetts
Phone Number(857) 343-8292
Industry
CEOMark Manfredi, Ph.D.
Websiteclinicaltrials.gov

Recent Stories